SCHEMBL13290548

SCHEMBL13290548

Cc1cc2cc(C(=O)N3CCN(CCO)CC3)ccc2s1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.52
▸ POLB P06746 2/20 0.52
▸ HTT P42858 1/20 0.48
▸ AKR1C3 P42330 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ TSHR P16473 1/20 0.44
▸ NAMPT P43490 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ ITK Q08881 1/20 0.41
▸ F2 P00734 1/20 0.41
▸ TPSAB1 Q15661 1/20 0.41
▸ TPSD1 Q9BZJ3 1/20 0.41
▸ TPSG1 Q9NRR2 1/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ TLR9 Q9NR96 1/20 0.41
▸ TLR8 Q9NR97 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13290540 0.78 ALDH1A1 (0.54) ALDH1A1POLBHTTAKR1C3KDM4E
SCHEMBL10211716 0.76 ALDH1A1 (0.69) ALDH1A1POLBAKR1C3KDM4EMAPT
SCHEMBL12217749 0.76 ALDH1A1 (0.58) ALDH1A1POLBHTTAKR1C3KDM4E
SCHEMBL13290542 0.75 ALDH1A1 (0.54) ALDH1A1POLBHTTAKR1C3KDM4E
SCHEMBL2378904 0.74 ALDH1A1 (0.56) ALDH1A1POLBHTTAKR1C3KDM4E
SCHEMBL12286133 0.74 HPGD (0.64) ALDH1A1POLBHTTAKR1C3KDM4E
SCHEMBL16132007 0.72 ALDH1A1 (0.56) ALDH1A1POLBAKR1C3KDM4EMAPT
SCHEMBL15651295 0.72 KMT2A (0.58) ALDH1A1POLBHTTKDM4EMAPT
SCHEMBL13290581 0.71 AKR1C3 (0.56) ALDH1A1POLBHTTAKR1C3MAPT
SCHEMBL15107941 0.70 ALDH1A1 (0.58) ALDH1A1POLBAKR1C3KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 — — US disclosed
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 — — US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 — — US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 ALDH1A1 3131/4885POLB 4110/4885HTT 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback